Showing results (951-960 of 1,072) with videos related to
Sort By:
Pageof 108
Bone|December 16, 2017
Sex hormones are negatively associated with vertebral bone marrow fatSwaroop D Mistry, Gina N Woods, Sigurdur Sigurdsson, et al.Journal of Neurosurgery|May 1, 2026
Individualized multiparadigm mapping and standardized tablet-based task administration during awake craniotomy: associations with return to work and survival in diffuse gliomasEsteban Ramirez Ferrer, Kyle Noll, David S Sabsevitz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2026
Systemic immune correlates of long-term survival after Delta-24-RGD based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)Chibawanye I Ene, Sanjay Singh, Thiagarajan Venkataraman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupSandeep Kunwar, Michael D Prados, Susan M Chang, et al.Scientific Reports|May 21, 2020
Infarct in new territory after endovascular stroke treatment: A diffusion-weighted imaging studyJohannes Kaesmacher, Christoph Kurmann, Noel Jungi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant GliomasAlessandro Canella, Alessandra M Welker, Ji Young Yoo, et al.Neuro-Oncology Advances|March 13, 2026
Perioperative neurocognitive functioning in elderly patients undergoing awake craniotomy for high grade gliomaEric A Goethe, Kyle R Noll, Subhiksha Srinivasan, et al.Cancer Research|May 3, 2013
miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of gliomaJun Wei, Fei Wang, Ling-Yuan Kong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2003
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical resultsFrederick F Lang, Janet M Bruner, Gregory N Fuller, et al.Neuro-Oncology|April 7, 2019
REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesisAnantha L Marisetty, Li Lu, Bethany L Veo, et al.Pageof 108